Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.

Stocks | Futures | Watchlist | More
or

Optinose Inc (OPTN)

Optinose Inc (OPTN)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 158,328
  • Shares Outstanding, K 53,309
  • Annual Sales, $ 49,120 K
  • Annual Income, $ -99,790 K
  • 60-Month Beta 0.99
  • Price/Sales 3.20
  • Price/Cash Flow N/A
  • Price/Book N/A
Trade OPTN with:

Options Overview Details

View History
  • Implied Volatility 142.75%
  • Historical Volatility 50.98%
  • IV Percentile 91%
  • IV Rank 56.51%
  • IV High 211.89% on 07/19/21
  • IV Low 52.89% on 05/20/21
  • Put/Call Vol Ratio 0.50
  • Today's Volume 3
  • Volume Avg (30-Day) 42
  • Put/Call OI Ratio 1.04
  • Today's Open Interest 192
  • Open Int (30-Day) 401

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 4 analysts offering recommendations.
Earnings Estimates - Current Qtr 09/30/21
See More
  • Average Estimate -0.37
  • Number of Estimates 2
  • High Estimate -0.36
  • Low Estimate -0.37
  • Prior Year -0.43
  • Growth Rate Est. (year over year) +13.95%

Price Performance

See More
Period Period Low Period High Performance
1-Month
2.62 +13.36%
on 09/15/21
3.25 -8.62%
on 08/31/21
+0.16 (+5.69%)
since 08/24/21
3-Month
2.32 +28.01%
on 08/11/21
3.50 -15.14%
on 06/28/21
-0.33 (-10.00%)
since 06/24/21
52-Week
2.32 +28.01%
on 08/11/21
5.11 -41.88%
on 11/19/20
-0.81 (-21.43%)
since 09/24/20

Most Recent Stories

More News
Optinose to Present at the Cantor Virtual Global Healthcare Conference

Optinose (NASDAQ:OPTN), a pharmaceutical company focused on patients treated by ear, nose and throat (ENT) and allergy specialists, today announced that Chief Executive Officer Peter Miller will present...

OPTN : 2.97 (+0.68%)
Optinose Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

OptiNose, Inc. (NASDAQ:OPTN), a pharmaceutical company focused on patients treated by ear, nose and throat (ENT) and allergy specialists, today announced that the company has granted non-qualified stock...

OPTN : 2.97 (+0.68%)
Bio-Techne Set to Join S&P 500; Saia, Mimecast & Option Care Health to Join S&P MidCap 400; Others to Join S&P SmallCap 600

/PRNewswire/ -- S&P Dow Jones Indices will make the following changes to the S&P 500, S&P MidCap 400, and S&P SmallCap 600 effective prior to the opening of trading on :

OPTN : 2.97 (+0.68%)
BLFS : 46.94 (-1.61%)
USCR : 73.99 (-0.01%)
ADI : 178.53 (+0.73%)
MIME : 66.60 (-0.05%)
MXIM : 103.14 (-1.18%)
OPCH : 24.51 (-4.33%)
SAIA : 243.27 (-0.02%)
SYKE : 54.00 (+0.04%)
TECH : 538.88 (+0.37%)
TRMK : 31.92 (+1.24%)
CNK : 18.84 (+0.11%)
VMC : 176.06 (-1.48%)
SPGI : 453.08 (+0.31%)
OptiNose (OPTN) Reports Q2 Loss, Tops Revenue Estimates

OptiNose (OPTN) delivered earnings and revenue surprises of -2.33% and 5.84%, respectively, for the quarter ended June 2021. Do the numbers hold clues to what lies ahead for the stock?

OPTN : 2.97 (+0.68%)
OptiNose: Q2 Earnings Snapshot

YARDLEY, Pa. (AP) _ OptiNose Inc. (OPTN) on Wednesday reported a loss of $23.5 million in its second quarter.

OPTN : 2.97 (+0.68%)
Optinose Reports Second Quarter 2021 Financial Results and Recent Operational Highlights

Second quarter 2021 XHANCE net revenue of $18.4 million increased 79% compared to second quarter 2020

OPTN : 2.97 (+0.68%)
Option Care Health Announces Upsizing and Pricing of Secondary Offering of 18,000,000 Shares of Common Stock

Option Care Health, Inc. ("Option Care Health" or the "Company") (NASDAQ: OPCH) announced today that an affiliate of Madison Dearborn Partners (the "Selling Stockholder") has agreed to sell 18,000,000...

OPTN : 2.97 (+0.68%)
OPCH : 24.51 (-4.33%)
Option Care Health Announces Secondary Offering of 15,000,000 Shares of Common Stock

Option Care Health, Inc. ("Option Care Health" or the "Company") (NASDAQ: OPCH) announced today that an affiliate of Madison Dearborn Partners (the "Selling Stockholder") has agreed to sell 15,000,000...

OPTN : 2.97 (+0.68%)
OPCH : 24.51 (-4.33%)
Option Care Health Announces Financial Results for the Second Quarter Ended June 30, 2021

Option Care Health, Inc. (the "Company" or "Option Care Health") (Nasdaq: OPCH), the nation's largest independent provider of home and alternate site infusion services, announced today financial results...

OPTN : 2.97 (+0.68%)
OPCH : 24.51 (-4.33%)
Optinose Completes Patient Recruitment in Pivotal Trial for XHANCE in Chronic Sinusitis

Company Expects Top-Line Results in First Quarter 2022

OPTN : 2.97 (+0.68%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 40% Sell with a Weakest short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

See More Share

Business Summary

OptiNose Inc. is a specialty pharmaceutical company. It focused on the development and commercialization of products for patients treated by ear, nose and throat or ENT and allergy specialists. The company's lead product consists of XHANCE nasal polyps, XHANCE Chronic sinusitis, OPN-300, OPN- 021 and...

See More

Key Turning Points

3rd Resistance Point 3.20
2nd Resistance Point 3.14
1st Resistance Point 3.05
Last Price 2.97
1st Support Level 2.90
2nd Support Level 2.84
3rd Support Level 2.75

See More

52-Week High 5.11
Fibonacci 61.8% 4.04
Fibonacci 50% 3.72
Fibonacci 38.2% 3.39
Last Price 2.97
52-Week Low 2.32

See More

Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar